Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
Keyword(s):
2016 ◽
Vol 22
(5)
◽
pp. 449-466
◽
Keyword(s):
2011 ◽
Vol 58
(6)
◽
pp. 274-282
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 51
(12)
◽
pp. 1460-1465
◽
Keyword(s):
2020 ◽
Vol 26
(9)
◽
pp. 1081-1089
Keyword(s):
Keyword(s):
Keyword(s):